What is the current Price Target for the Centessa Pharmaceuticals plc - ADR stock?

The average Centessa Pharmaceuticals plc - ADR target price is $31.75. This is 181.72% higher than the current stock price. The highest price target is 237.18%, the lowest is 139.57%. 8 Analysts have issued a price target Centessa Pharmaceuticals plc - ADR 2026 .

How high will the Centessa Pharmaceuticals plc - ADR stock rise?

No reliable answer can be given as to how high the Centessa Pharmaceuticals plc - ADR stock will rise. The performance of stocks, including the Centessa Pharmaceuticals plc - ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Centessa Pharmaceuticals plc - ADR stock today?

The performance of Centessa Pharmaceuticals plc - ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Centessa Pharmaceuticals plc - ADR stock fall?

The decline in Centessa Pharmaceuticals plc - ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Centessa Pharmaceuticals plc - ADR Forecast, price target & analysts

$11.27

4.17% yesterday

Nasdaq, Apr 10, 10:00 pm CET

ISIN

US1523091007

Symbol

CNTA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Centessa Pharmaceuticals plc - ADR Target price 2025 - Analyst rating & recommendation

Centessa Pharmaceuticals plc - ADR Classifications & Recommendation:

Buy

100%

Centessa Pharmaceuticals plc - ADR Price Target

Target Price	$31.75
Price	$11.27
Potential	181.72% register free of charge
Number of Estimates	8

	8 Analysts have issued a price target Centessa Pharmaceuticals plc - ADR 2026 . The average Centessa Pharmaceuticals plc - ADR target price is $31.75. This is 181.72% register free of charge higher than the current stock price. The highest price target is $38.00 237.18% register free of charge , the lowest is $27.00 139.57% register free of charge .
	A rating was issued by 10 analysts: 10 Analysts recommend Centessa Pharmaceuticals plc - ADR to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Centessa Pharmaceuticals plc - ADR stock has an average upside potential 2026 of 181.72% register free of charge . Most analysts recommend the Centessa Pharmaceuticals plc - ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.06	-1.49
	30.38%	27.67%
P/E		negative

5 Analysts have issued a Centessa Pharmaceuticals plc - ADR forecast for earnings per share. The average Centessa Pharmaceuticals plc - ADR EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.06	30.38%
2025	$-1.49 27.67% Unlock
2026	$-1.46 2.01% Unlock
2027	$-1.55 6.16% Unlock
2028	$-1.47 5.16% Unlock
2029	$0.25 117.01% Unlock

Current	-5.67	16.74%
2025	-7.56 33.33% Unlock
2026	-7.72 2.12% Unlock
2027	-7.26 5.96% Unlock
2028	-7.65 5.37% Unlock
2029	45.08 689.28% Unlock

Centessa Pharmaceuticals plc - ADR...

Current Centessa Pharmaceuticals plc - ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Piper Sandler	Locked ➜ Locked	Locked	Mar 31 2025
Guggenheim	Locked ➜ Locked	Locked	Mar 26 2025
Guggenheim	Locked ➜ Locked	Locked	Feb 10 2025
TD Cowen	Locked ➜ Locked	Locked	Jan 07 2025
Guggenheim	Locked ➜ Locked	Locked	Nov 15 2024
B. Riley Securities	Locked ➜ Locked	Locked	Sep 19 2024
Morgan Stanley	Locked ➜ Locked	Locked	Sep 19 2024

Analyst Rating	Date
Locked Piper Sandler: Locked ➜ Locked	Mar 31 2025
Locked Guggenheim: Locked ➜ Locked	Mar 26 2025
Locked Guggenheim: Locked ➜ Locked	Feb 10 2025
Locked TD Cowen: Locked ➜ Locked	Jan 07 2025
Locked Guggenheim: Locked ➜ Locked	Nov 15 2024
Locked B. Riley Securities: Locked ➜ Locked	Sep 19 2024
Locked Morgan Stanley: Locked ➜ Locked	Sep 19 2024

Discover more stocks with a high price target

Novo Nordisk 90.54%

MongoDB 78.62%

TUI 68.73%

Coinbase Global, Inc. 67.18%

Infineon 60.61%

NIO ADR 59.99%

NVIDIA 57.87%

Alibaba Group Holding Ltd 52.22%

BioNTech SE - ADR 50.44%

Walt Disney 48.21%

PayPal 47.01%

Adyen 45.04%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now